In an era of precision medicine, massive amounts of structured and unstructured data are accumulated per patient. The amount of medical data is expected to double every 73 days by 2020. Big Data is becoming a major topic for the biopharma industry, despite a low level of digitization compared to other sectors. Adopting digital technologies is a prerequisite for gaining actionable insights from health and disease related data and to deliver on the promises of precision medicine. The PERMIDES EU Project aims to accelerate the digitalization of biopharma SMEs via connecting them to suitable bioinformatics and IT partners and funding joint innovation projects.
“BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.
The session organised by the project discussed trends, challenges and opportunities associated with the digitalization of the biopharma value chain. Speakers with complementary backgrounds and expertise shared their insights and discuss with SMEs pitching their case studies and innovation projects facilitated via PERMIDES.
Check out particpants and pitches here.